Evidence map›Paper›PMID 34545764›Full record

ArticleThe British journal of radiology2021

Descriptive analysis of MRI functional changes occurring during reduced dose radiotherapy for myxoid liposarcomas.

Evanthia Kousi, Christina Messiou, Aisha Miah, Matthew Orton, Rick Haas, Khin Thway, Georgina Hopkinson, Shane Zaidi, Myles Smith, Elizabeth Barquin and 5 more

Open access · greenAbstract read
In one paragraph

Article in The British journal of radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Features of MR Imaging that Differentiate between Immunohistochemically Diagnosed Dedifferentiated Liposarcoma and Myxoid Liposarcoma.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2025
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Evanthia KousiMRI unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK.
Christina MessiouRadiology department, The Royal Marsden NHS Foundation Trust, London, UK.
Aisha MiahSarcoma Unit, The Royal Marsden NHS Foundation Trust, London, UK.
Matthew OrtonMRI unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK.
Rick HaasSarcoma Unit, Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Khin ThwayMolecular pathology, The Royal Marsden NHS Foundation Trust, London, UK.
Georgina HopkinsonMRI unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK.
Shane ZaidiSarcoma Unit, The Royal Marsden NHS Foundation Trust, London, UK.
Myles SmithSarcoma Unit, The Royal Marsden NHS Foundation Trust, London, UK.
Elizabeth BarquinSarcoma Unit, The Royal Marsden NHS Foundation Trust, London, UK.
Eleanor MoskovicRadiology department, The Royal Marsden NHS Foundation Trust, London, UK.
Nicos FotiadisDepartment of Interventional Radiology, The Royal Marsden NHS Foundation trust, London, UK.
Dirk StraussSarcoma/Melanoma Unit, The Royal Marsden NHS Foundation Trust, London, UK.
Andrew HayesSarcoma/Melanoma Unit, The Royal Marsden NHS Foundation Trust, London, UK.
Maria A SchmidtMRI unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK.
Royal Marsden NHS Foundation Trust · GBInstitute of Cancer Research · GBLeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesMyxoid liposarcomas (MLS) show enhanced response to radiotherapy due to their distinctive vascular pattern and therefore could be effectively treated with lower radiation doses. This is a descriptive study to explore the use of functional MRI to identify response in a uniform cohort of MLS patients treated with reduced dose radiotherapy.

methods10 patients with MLS were imaged pre-, during, and post-radiotherapy receiving reduced dose radiotherapy and the response to treatment was histopathologically assessed post-radiotherapy. Apparent diffusion coefficient (ADC), T2* relaxation time, volume transfer constant (Ktrans), initial area under the gadolinium curve over 60 s (IAUGC60) and (Gd) were estimated for a central tumour volume.

resultsAll parameters showed large inter- and intrasubject variabilities. Pre-treatment (Gd), IAUGC60 and Ktrans were significantly different between responders and non-responders. Post-radiotherapy reductions from baseline were demonstrated for T2*, (Gd), IAUGC60 and Ktrans for responders. No statistically significant ADC differences were demonstrated between the two response groups. Significantly greater early tumour volume reductions were observed for responders.

conclusionsMLS are heterogenous lesions, characterised by a slow gradual contrast-agent uptake. Pre-treatment vascular parameters, early changes to tumour volume, vascular parameters and T2* have potential in identifying response to treatment. The delayed (Gd) is a suitable descriptive parameter, relying simply on T1 measurements. Volume changes precede changes in MLS functionality and could be used to identify early response. ADVANCES IN KNOWLEDGE: MLS are are characterised by slow gradual contrast-agent uptake. Measurement of the delayed contrast-agent uptake (Gd) is simple to implement and able to discriminate response.

Indexed as

AdultContrast MediaDiffusion Magnetic Resonance ImagingFemaleHumansLiposarcoma, MyxoidMaleMiddle AgedPilot ProjectsRadiotherapy, ConformalRadiotherapy DosageRadiotherapy, Intensity-ModulatedTumor BurdenContrast Media

Identifiers

PMID34545764
PMCPMC9328045
OpenAlexW3201582852

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.